QQQ   444.01 (-0.18%)
AAPL   171.48 (-1.06%)
MSFT   420.72 (-0.17%)
META   485.58 (-1.68%)
GOOGL   150.93 (+0.04%)
AMZN   180.38 (+0.31%)
TSLA   175.79 (-2.25%)
NVDA   903.56 (+0.12%)
NIO   4.50 (-3.64%)
AMD   180.49 (+0.50%)
BABA   72.36 (+1.08%)
T   17.60 (+0.28%)
F   13.28 (+1.68%)
MU   117.89 (-1.14%)
CGC   8.63 (-9.63%)
GE   175.53 (-2.55%)
DIS   122.36 (+1.14%)
AMC   3.72 (-14.29%)
PFE   27.75 (-0.11%)
PYPL   66.99 (+0.63%)
XOM   116.24 (+1.10%)
QQQ   444.01 (-0.18%)
AAPL   171.48 (-1.06%)
MSFT   420.72 (-0.17%)
META   485.58 (-1.68%)
GOOGL   150.93 (+0.04%)
AMZN   180.38 (+0.31%)
TSLA   175.79 (-2.25%)
NVDA   903.56 (+0.12%)
NIO   4.50 (-3.64%)
AMD   180.49 (+0.50%)
BABA   72.36 (+1.08%)
T   17.60 (+0.28%)
F   13.28 (+1.68%)
MU   117.89 (-1.14%)
CGC   8.63 (-9.63%)
GE   175.53 (-2.55%)
DIS   122.36 (+1.14%)
AMC   3.72 (-14.29%)
PFE   27.75 (-0.11%)
PYPL   66.99 (+0.63%)
XOM   116.24 (+1.10%)
QQQ   444.01 (-0.18%)
AAPL   171.48 (-1.06%)
MSFT   420.72 (-0.17%)
META   485.58 (-1.68%)
GOOGL   150.93 (+0.04%)
AMZN   180.38 (+0.31%)
TSLA   175.79 (-2.25%)
NVDA   903.56 (+0.12%)
NIO   4.50 (-3.64%)
AMD   180.49 (+0.50%)
BABA   72.36 (+1.08%)
T   17.60 (+0.28%)
F   13.28 (+1.68%)
MU   117.89 (-1.14%)
CGC   8.63 (-9.63%)
GE   175.53 (-2.55%)
DIS   122.36 (+1.14%)
AMC   3.72 (-14.29%)
PFE   27.75 (-0.11%)
PYPL   66.99 (+0.63%)
XOM   116.24 (+1.10%)
QQQ   444.01 (-0.18%)
AAPL   171.48 (-1.06%)
MSFT   420.72 (-0.17%)
META   485.58 (-1.68%)
GOOGL   150.93 (+0.04%)
AMZN   180.38 (+0.31%)
TSLA   175.79 (-2.25%)
NVDA   903.56 (+0.12%)
NIO   4.50 (-3.64%)
AMD   180.49 (+0.50%)
BABA   72.36 (+1.08%)
T   17.60 (+0.28%)
F   13.28 (+1.68%)
MU   117.89 (-1.14%)
CGC   8.63 (-9.63%)
GE   175.53 (-2.55%)
DIS   122.36 (+1.14%)
AMC   3.72 (-14.29%)
PFE   27.75 (-0.11%)
PYPL   66.99 (+0.63%)
XOM   116.24 (+1.10%)
NASDAQ:CUTR

Cutera (CUTR) Stock Price, News & Analysis

$1.47
+0.08 (+5.76%)
(As of 05:21 PM ET)
Today's Range
$1.39
$1.58
50-Day Range
$1.39
$3.04
52-Week Range
$1.28
$27.16
Volume
982,568 shs
Average Volume
1.85 million shs
Market Capitalization
$29.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.75

Cutera MarketRank™ Stock Analysis

Analyst Rating
Hold
2.40 Rating Score
Upside/​Downside
903.4% Upside
$14.75 Price Target
Short Interest
Bearish
38.37% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.28mentions of Cutera in the last 14 days
Based on 14 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($5.79) to ($2.70) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.07 out of 5 stars

Computer And Technology Sector

510th out of 588 stocks

Electromedical Equipment Industry

16th out of 20 stocks

CUTR stock logo

About Cutera Stock (NASDAQ:CUTR)

Cutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truFlex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; and excel V+, a vascular and benign pigmented lesion treatment platform. It also offers truSculpt, a high-powered radio frequency system designed for circumferential reduction, lipolysis, and deep tissue heating and treat all body and skin types; Secret RF, a fractional RF microneedling device that delivers heat into the deeper layers of the skin using controlled RF energy; and enlighten, a laser platform with a dual wavelength for multi-colored tattoo removal, and the treatment of benign pigmented lesions and acne scars. In addition, the company provides excel HR, a hair removal solution for all skin types; and xeo, a multi-application platform for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. Further, it offers its products through direct sales and services, and network of distributors and direct international sales. Cutera, Inc. was incorporated in 1998 and is headquartered in Brisbane, California.

CUTR Stock Price History

CUTR Stock News Headlines

$25,000 into $109,616 in two months?
Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…
Cutera (NASDAQ:CUTR) Stock Rating Upgraded by William Blair
Cutera's (CUTR) Overweight Rating Reiterated at Stephens
Why Cutera Shares Are Diving Today
Cutera earnings: here's what Wall Street expects
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
Earnings Preview For Cutera
Cutera Inc. hosts conference call for investors
CUTR Apr 2024 6.000 call
Cutera Inc
CUTR Mar 2024 6.000 put
MVIS Mar 2024 1.500 call
MVIS Mar 2024 1.000 put
See More Headlines
Receive CUTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cutera and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/05/2024
Today
3/28/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Current Symbol
NASDAQ:CUTR
Employees
540
Year Founded
1998

Price Target and Rating

Average Stock Price Target
$14.75
High Stock Price Target
$21.00
Low Stock Price Target
$10.00
Potential Upside/Downside
+961.2%
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
5 Analysts

Profitability

Net Income
$-150,830,000.00
Pretax Margin
-70.30%

Debt

Sales & Book Value

Annual Sales
$212.37 million
Book Value
($8.01) per share

Miscellaneous

Free Float
19,525,000
Market Cap
$27.72 million
Optionable
Optionable
Beta
1.70

Social Links

The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Dr. Michael A. Karavitis Ph.D. (Age 54)
    Executive VP & Chief Technology Officer
    Comp: $595.8k
  • Mr. Taylor C. Harris (Age 48)
    President, CEO & Director
  • Mr. Stuart Drummond
    Interim Chief Financial Officer
  • Mr. Jeffrey S. Jones (Age 68)
    Chief Operating Officer
  • Mr. Charles G. Thier (Age 61)
    Chief Information Officer
    Comp: $620.84k
  • Anne Werdan
    Director of Investor Relations
  • Dr. Stephana E. Patton J.D. (Age 53)
    Ph.D., Chief Legal Officer
  • Mr. Steve Kreider
    Senior Vice President of Global Marketing
  • Mr. Brent Hauser (Age 47)
    President of International

CUTR Stock Analysis - Frequently Asked Questions

Should I buy or sell Cutera stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cutera in the last twelve months. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CUTR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CUTR, but not buy additional shares or sell existing shares.
View CUTR analyst ratings
or view top-rated stocks.

What is Cutera's stock price target for 2024?

5 equities research analysts have issued 1-year price targets for Cutera's shares. Their CUTR share price targets range from $10.00 to $21.00. On average, they predict the company's share price to reach $14.75 in the next year. This suggests a possible upside of 903.4% from the stock's current price.
View analysts price targets for CUTR
or view top-rated stocks among Wall Street analysts.

How have CUTR shares performed in 2024?

Cutera's stock was trading at $3.53 on January 1st, 2024. Since then, CUTR shares have decreased by 58.4% and is now trading at $1.47.
View the best growth stocks for 2024 here
.

When is Cutera's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our CUTR earnings forecast
.

How were Cutera's earnings last quarter?

Cutera, Inc. (NASDAQ:CUTR) released its earnings results on Tuesday, March, 5th. The medical device company reported ($2.22) earnings per share for the quarter. The medical device company earned $46.48 million during the quarter.

What ETF holds Cutera's stock?

SPDR S&P Health Care Equipment ETF holds 517,362 shares of CUTR stock, representing 1.65% of its portfolio.

What guidance has Cutera issued on next quarter's earnings?

Cutera updated its FY 2024 earnings guidance on Thursday, March, 21st. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $160.0 million-$170.0 million, compared to the consensus revenue estimate of $168.3 million.

What is David H. Mowry's approval rating as Cutera's CEO?

1 employees have rated Cutera Chief Executive Officer David H. Mowry on Glassdoor.com. David H. Mowry has an approval rating of 100% among the company's employees. This puts David H. Mowry in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Cutera own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cutera investors own include NVIDIA (NVDA), QUALCOMM (QCOM), AbbVie (ABBV), Micron Technology (MU), Gilead Sciences (GILD), Alibaba Group (BABA), DocuSign (DOCU), Pfizer (PFE), Block (SQ) and Twilio (TWLO).

Who are Cutera's major shareholders?

Cutera's stock is owned by many different retail and institutional investors. Top institutional shareholders include Findell Capital Management LLC (55.57%), Opti Capital Management LP (32.60%), RTW Investments LP (9.12%), Vanguard Group Inc. (5.08%), Vanguard Group Inc. (5.08%) and Gamco Investors INC. ET AL (4.45%). Insiders that own company stock include David H Mowry, J Daniel Plants, Joseph E Whitters, Katherine S Zanotti, Rohan Seth, Stuart Drummond, Taylor C Harris and Timothy J Oshea.
View institutional ownership trends
.

How do I buy shares of Cutera?

Shares of CUTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CUTR) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners